Evidence map›Paper›PMID 42894972›Full record

Trial reportJournal of microbiology and biotechnology2026

Heat-treated

Jin Joo Lee, Ji-Won Song, Hyeon Jeong Kim, Jung Hoon In, Jisoo Park, Jongsun Park, Seunghun Lee

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jin Joo LeeBiohealthcare R&D Center, HYUNDAI BIOLAND Co., Ltd., Ansan 15407, Republic of Korea.
Ji-Won SongBiohealthcare R&D Center, HYUNDAI BIOLAND Co., Ltd., Ansan 15407, Republic of Korea.
Hyeon Jeong KimBiohealthcare R&D Center, HYUNDAI BIOLAND Co., Ltd., Ansan 15407, Republic of Korea.
Jung Hoon InBiohealthcare R&D Center, HYUNDAI BIOLAND Co., Ltd., Ansan 15407, Republic of Korea.
Jisoo ParkMitos Biomedical Institute, Mitos Therapeutics Inc, Daejeon 34134, Republic of Korea.
Jongsun ParkMitos Biomedical Institute, Mitos Therapeutics Inc, Daejeon 34134, Republic of Korea.
Seunghun LeeBiohealthcare R&D Center, HYUNDAI BIOLAND Co., Ltd., Ansan 15407, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Age-related sarcopenia is a condition characterized by a decline in muscle strength and physical function with aging, and its improvement is important given its close association with falls, fractures, and mortality. Recently, as the link between age-related gut microbiota dysbiosis and sarcopenia has been elucidated, modulation of the gut microbiota has gained attention as a therapeutic strategy for sarcopenia. In particular, with growing interest in paraprobiotics, various health-promoting effects-including gut microbiota modulation and improvement of muscle strength-have been reported. However, clinical evidence supporting the association between the gut microbiota and muscle strength remains limited. Accordingly, this clinical study was conducted to investigate the effects of heat-treated

Indexed as

Gastrointestinal MicrobiomeLactiplantibacillus plantarumMuscle StrengthProbioticsSarcopeniaAgedAged, 80 and overBacteriaFecesFemaleHand StrengthHot TemperatureHumansMaleGut microbiotaHeat-treated Lactiplantibacillus plantarumMuscle strength

Identifiers

PMID42894972
PMCPMC13686804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.